Longitude Capital
Venture capital · Menlo Park, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
13Deep-tech portfolio5 active
8Portfolio exitsAcquired or listed
3Raises, 12 monthsLatest: Gossamer Bio
32Co-investorsShare a portfolio company
Portfolio · 13 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Aviceda Therapeutics | Biotech | Active | Jan 13, 2025 | $98.6M |
| Imvax | Biotech | Active | Jul 30, 2020 | $151.8M |
| Alentis Therapeutics | Biotech | Active | — | — |
| Alpha-9 Oncology | Biotech | Active | — | — |
| Lassen Therapeutics | Biotech | Active | — | — |
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Veradermics | Biotech | Public | May 15, 2026 | $269.3M |
| Mirum Pharmaceuticals | Biotech | Public | Jan 29, 2026 | $138.5M |
| CytomX Therapeutics | Biotech | Public | Aug 17, 2023 | $143.0M |
| Vigil Neuroscience | Biotech | Acquired | Aug 29, 2022 | $195.0M |
| Viridian Therapeutics | Biotech | Public | Sep 29, 2020 | $29.0M |
| CG Oncology | Biotech | Public | — | — |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#36
Portfolio exits#20
Raises, 12 months#5
Co-investors#55
Co-investors
- Atlas VentureVenture capital3 shared
- LifeSci Venture PartnersVenture capital3 shared
- Catalio Capital ManagementVenture capital2 shared
- PJCVenture capital2 shared
- RA CapitalVenture capital2 shared
- SR OneVenture capital2 shared
- Versant VenturesVenture capital2 shared
- Aisling CapitalVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- BioAdvanceVenture capital1 shared
Sectors
- Biotech13
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.